STOCK TITAN

Vireo Growth Inc. to Release Second Quarter 2024 Results on August 6, 2024

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Very Positive)
Tags

Vireo Growth Inc. (CSE: VREO; OTCQX: VREOF), a cannabis company, has announced the release of its second quarter 2024 financial results on August 6, 2024, after market close. The company will host a conference call with investors on the same day at 4:30 p.m. ET to discuss the results. Interested parties can join the call by dialing 1-800-715-9871 (US and Canada, Toll-Free) or 1-646-307-1963 (International, Toll) with conference ID 3718174. A live audio webcast will also be available on the company's Investor Relations website.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction 1 Alert

+0.02% News Effect

On the day this news was published, VREOF gained 0.02%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

MINNEAPOLIS, July 23, 2024 (GLOBE NEWSWIRE) -- Vireo Growth Inc. (formerly Goodness Growth Holdings, Inc.) ("Vireo" or the "Company") (CSE: VREO; OTCQX: VREOF), a cannabis company committed to providing safe access, quality products and great value to its customers, today announced that it will release its financial results for its second quarter ended June 30, 2024 on Tuesday, August 6, 2024 after the market closes.

Vireo management will host a conference call with the investment community that day, Tuesday, August 6, 2024 at 4:30 p.m. ET (3:30 p.m. CT) to discuss its results. Interested parties may attend the conference call by dialing 1-800-715-9871 (Toll-Free) (US and Canada) or 1-646-307-1963 (Toll) (International) and referencing conference ID number 3718174.

A live audio webcast of this event will also be available in the Events & Presentations section of the Company’s Investor Relations website and via the following link: https://events.q4inc.com/attendee/837840088.

About Vireo Growth Inc.

Vireo was founded as a pioneer in medical cannabis in 2014 and we are fueled by an entrepreneurial drive that sustains our ongoing commitment to serve and delight our key stakeholders, most notably our customers, our employees, our shareholders, our industry collaborators, and the communities in which we live and operate. We work every day to get better and our team prioritizes 1) empowering and supporting strong local market leaders and 2) strategic, prudent capital and human resource allocation. For more information, please visit www.vireogrowth.com.

Contact Information

Investor Inquiries:
Sam Gibbons
Investor Relations
investor@vireogrowth.com
(612) 314-8995

Media Inquiries:
Amanda Hutcheson
Senior Manager, Communications
amandahutcheson@vireogrowth.com  
(919) 815-1476


FAQ

When will Vireo Growth Inc. (VREOF) release its Q2 2024 financial results?

Vireo Growth Inc. (VREOF) will release its second quarter 2024 financial results on August 6, 2024, after the market closes.

What time is Vireo Growth Inc.'s (VREOF) Q2 2024 earnings call scheduled for?

Vireo Growth Inc.'s (VREOF) Q2 2024 earnings call is scheduled for August 6, 2024, at 4:30 p.m. ET (3:30 p.m. CT).

How can investors join Vireo Growth Inc.'s (VREOF) Q2 2024 earnings call?

Investors can join Vireo Growth Inc.'s (VREOF) Q2 2024 earnings call by dialing 1-800-715-9871 (US and Canada, Toll-Free) or 1-646-307-1963 (International, Toll) and using conference ID 3718174. A live audio webcast will also be available on the company's Investor Relations website.

What is Vireo Growth Inc.'s stock symbol on the OTCQX?

Vireo Growth Inc.'s stock symbol on the OTCQX is VREOF.
Vireo Growth Inc

OTC:VREOF

VREOF Rankings

VREOF Latest News

VREOF Latest SEC Filings

VREOF Stock Data

438.51M
762.00M
23.53%
12.66%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States
Minneapolis